The European Medicines Agency (EMA) recommended marketing authorization for Exviera (dasabuvir) and Viekirax (ombitasvir + paritaprevir + ritonavir) combined with other therapies and products to treat chronic hepatitis C virus (HCV) infections. Both ... Read more